MedTrace Logo

The Effect of Tart Cherry (Prunus Cerasus) Concentrate on Physiological and Cognitive Function

NCT04021342 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2021-04-08

No results posted yet for this study

Summary

A randomized, double blind, counterbalanced, placebo controlled independent groups design to determine the effects of 3 month supplementation with tart cherry concentrate on indices of cardiometabolic health, exercise capacity and cognitive function. Following screening and recruitment, participants are familiarised with the testing equipment and procedures after which they will be randomly assigned to receive either Montmorency tart cherry concentrate (MC) or an isocaloric placebo (PLA), stratified by gender. The study is comprised of two experimental visits and outcome variables are assessed at baseline (before supplementation) and at 3 months (follow up; after supplementation).

Conditions

  • Cardiometabolic Risk Factors
  • Cognitive Function
  • Exercise Capacity

Interventions

DIETARY_SUPPLEMENT

Montmorency tart cherry concentrate

Based on previous analysis done by our laboratory each 60 ml of Montmorency tart cherry concentrate contains approximately 73.5 mg of anthocyanins (cyanidin-3-glucoside equivalents) and 178.8 mg of total phenolics (mean gallic acid equivalents)

DIETARY_SUPPLEMENT

Placebo

Placebo beverage matched for calorie content and visual properties of the cherry concentrate

Sponsors & Collaborators

  • Cherry Marketing Institute

    collaborator UNKNOWN

  • Northumbria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2019-11-29
Completion
2020-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021342 on ClinicalTrials.gov